“Clinical Efficacy of the Human Tyrosinase Inhibitor Thiamidol (isobutylamido Thiazolyl Resorcinol) in Melasma”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 2, Mar. 2025, p. s544, https://doi.org/10.25251/skin.10.supp.544.